-
1
-
576: Patient Randomization Factors in the P53 Targeted Therapy Trial in Bladder Cancer (SWOG 4B951)
-
Tuazon, Ellenie D.;
Groshen, Susan G.;
Lerner, Seth P.;
Stadler, Walter;
Stein, John P.;
Cote, Richard J.;
;
(The Journal of urology : official journal of the American Urological Association, Inc,
v.177,
2007,
pp.192-192)
-
2
-
53 POSTER Combination treatment of VEGFR inhibitor AV-951 and rapamycin reveals distinct mechanisms of each agents anti-tumor activity
-
Robinson, M.;
Lin, J.;
Yang, H.;
Sun, X.;
Ona, V.;
Kannan, K.;
Heyer, J.;
Meng, G.;
Zhou, Y.;
Rideout, W.;
;
(EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics,
v.2008,
2008,
pp.20)
-
3
-
Abstract 951: Setdb1 deletion protects against formation of pancreatic ductal adenocarcinoma through inducing apoptosis and upregulating p53 expression
-
Ogawa, Satoshi;
Fukuda, Akihisa;
Tsuda, Motoyuki;
Masuda, Tomonori;
Sono, Makoto;
Fukunaga, Yuichi;
Yoshikawa, Takaaki;
Araki, Osamu;
Nagao, Munemasa;
Goto, Norihiro;
Hiramatsu, Yukiko;
Maruno, Takahisa;
Shinkai, Yoichi;
Seno, Hiroshi;
;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.79,
2019,
pp.951-951)
-
4
-
Epidemiology of lower gastrointestinal bleeding in China: Single‐center series and systematic analysis of Chinese literature with 53 951 patients
-
Bai, Yu;
Peng, Jun;
Gao, Jun;
Zou, Duo‐
Wu;
Li, Zhao‐
Shen;
Digestive Endoscopy Center, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China;
Library of Second Military Medical University, Shanghai, China;
Digestive Endoscopy Center, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China;
Digestive Endoscopy Center, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China;
Digestive Endoscopy Center, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China;
(Journal of gastroenterology and hepatology,
v.26,
2011,
pp.678-682)
-
5
-
53 POSTER Combination treatment of VEGFR inhibitor AV-951 and rapamycin reveals distinct mechanisms of each agent's anti-tumor activity
-
Robinson, M.;
Lin, J.;
Yang, H.;
Sun, X.;
Ona, V.;
Kannan, K.;
Heyer, J.;
Meng, G.;
Zhou, Y.;
Rideout, W.;
;
(EJC supplements,
v.6,
2008,
pp.20)
-
6
-
<b>Commentary on</b>McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A Fatality Involving Moclobemide, Sertraline and Pimozide. J Forensic Sci 1997;42:951-53
-
Desta, Zeruesenay;
Flockhart, David A.;
Division of Clinical Pharmacology Georgetown University Medical Center 3800 Reservoir Road N.W., Washington D.C., 20007, US.;
Division of Clinical Pharmacology Georgetown University Medical Center 3800 Reservoir Road N.W., Washington D.C., 20007, US.;
(Journal of forensic sciences,
v.44,
1999,
pp.14444J)
-
7
-
Tommi Lehtonen and Timo Koistinen (eds.) <i>Perspectives in Contemporary Philosophy of Religion</i>. (Helsinki: Luther-Agricola-Society, 2000). Pp. 255. Pbk. ISBN 951 9047 53 0.
-
SCOTT, MICHAEL;
;
(Religious studies,
v.38,
2002,
pp.363-369)
-
8
-
Evaluation of wood packwall supports - Barczak, T M; Tasillo, C; Gallant, W D CIM Bull V84, N951, July 1991, P53-57
-
;
;
(International journal of rock mechanics and mining sciences & geomechanics abstracts,
v.29,
1992,
pp.A113)
-
9
-
Commentary on McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A fatality involving moclobemide, sertraline and pimozide. J Forensic Sci 1997;42:951-53.
-
Desta, Z;
Flockhart, D A;
;
(Journal of forensic sciences,
v.44,
1999,
pp.231-232)
-
10
-
<i>Helicobacter pylori oipA</i> genetic diversity and its associations with both disease and <i>cagA</i>, <i>vacA</i> s, m, and i alleles among Bulgarian patients
-
Markovska, Rumyana;
Boyanova, Lyudmila;
Yordanov, Daniel;
Gergova, Galina;
Mitov, Ivan;
Corresponding author. Tel.: +359-2-91-72-523;
fax: +359-2-951-53-17.;
(Diagnostic microbiology and infectious disease,
v.71,
2011,
pp.335-340)